🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
5-Drug Combination Chemotherapy with Hematologic Toxicity Attenuation. Etop...
Status
Completed
Location
Holy Cross Hospital, Fort Lauderdale
Start Date
1993-05-08
Trial ID
NCT00001337
The primary objective is to evaluate the tolerability and efficacy of CWT-f...
Status
Completed
Location
Andover Research Eye Institute
Start Date
2022-12-12
Trial ID
NCT05660681
Treatments Being Tested
This study is an exploratory trial evaluating the tear film break-up time a...
Status
Completed
Location
University of Rochester Eye Institute
Start Date
2008-06
Trial ID
NCT00681265
Treatments Being Tested
The purpose of the study is to analyze the sensation to eye drops containin...
Status
Completed
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02985827
Treatments Being Tested
Children undergoing chemotherapy, radiation treatment and Hematopoietic Ste...
Status
Completed
Location
University of California
Start Date
2016-07-28
Trial ID
NCT02617407
The research will explore outcomes of different service delivery models of ...
Status
Recruiting
Location
University of Colorado School of Medicine
Start Date
2024-11-13
Trial ID
NCT06689865
The objective of this 1 week trial is to evaluate the efficacy of an over-t...
Status
Completed
Location
Stephens & Associates (Colorado Research Center)
Start Date
2016-02
Trial ID
NCT02691507
Treatments Being Tested
The goal of this clinical trial is to compare two methods of self assessmen...
Status
Not Yet Recruiting
Location
National Acoustic Laboratories
Start Date
2026-08-15
Trial ID
NCT07738237
Treatments Being Tested
This is a three-week crossover study that will compare how the body absorbs...
Status
Completed
Location
Oregon Health & Science University
Start Date
2018-06-08
Trial ID
NCT03493841
Treatments Being Tested